Insulin-Like Growth Factor System in Cancer: Novel Targeted Therapies
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin-Like Growth Factor System in Cancer: Novel Targeted Therapies
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-24
Publisher
Hindawi Limited
Online
2015-03-20
DOI
10.1155/2015/538019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insulin-like Growth Factor Binding Protein 7 Mediates Glioma Cell Growth and Migration
- (2015) Wei Jiang et al. NEOPLASIA
- IGFBP-4 Anti-Angiogenic and Anti-Tumorigenic Effects Are Associated with Anti-Cathepsin B Activity
- (2015) María J Moreno et al. NEOPLASIA
- Exogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancer
- (2014) C-L Soh et al. BRITISH JOURNAL OF CANCER
- Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells
- (2014) M Mancini et al. BRITISH JOURNAL OF CANCER
- Targeting cancer stem cells by curcumin and clinical applications
- (2014) Yanyan Li et al. CANCER LETTERS
- Insulin-like growth factor binding protein-related protein 1 and cancer
- (2014) Shuzhen Zhu et al. CLINICA CHIMICA ACTA
- Crosstalk between IGF-1R and other Tumor Promoting Pathways
- (2014) Changyu Liu et al. CURRENT PHARMACEUTICAL DESIGN
- IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor–stroma interaction
- (2014) C Rupp et al. ONCOGENE
- Insulin-Like Growth Factors and Insulin-Like Growth Factor-Binding Proteins and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
- (2013) M. L. Neuhouser et al. Cancer Prevention Research
- Prohibitin-2 Binding Modulates Insulin-like Growth Factor-binding Protein-6 (IGFBP-6)-induced Rhabdomyosarcoma Cell Migration
- (2013) Ping Fu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ISNN Society News
- (2013) Journal of Nutrigenetics and Nutrigenomics
- Anticarcinogenic effect of quercetin by inhibition of insulin-like growth factor (IGF)-1 signaling in mouse skin cancer
- (2013) Minjeong Jung et al. Nutrition Research and Practice
- Megakaryocytes co-localise with hemopoietic stem cells and release cytokines that up-regulate stem cell proliferation
- (2013) Shen Y. Heazlewood et al. Stem Cell Research
- Targeting the insulin-like growth factor-1 receptor in human cancer
- (2013) Alexandre Arcaro Frontiers in Pharmacology
- Natural Products: Promising Resources for Cancer Drug Discovery
- (2012) Susmita Mondal et al. Anti-Cancer Agents in Medicinal Chemistry
- The Insulin Receptor/Insulin-Like Growth Factor Receptor Family as a Therapeutic Target in Oncology
- (2012) M. Pollak CLINICAL CANCER RESEARCH
- Insulin-like growth factor-binding protein-6 and cancer
- (2012) Leon A. Bach et al. CLINICAL SCIENCE
- Insulin-like Growth Factor-1 Receptor (IGF-1R) Kinase Inhibitors in Cancer Therapy: Advances and Perspectives
- (2012) Mengzhu Xue et al. CURRENT PHARMACEUTICAL DESIGN
- Targeting the Insulin Growth Factor Receptor 1
- (2012) Fernanda I. Arnaldez et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Insulin-like Growth Factor Receptor Inhibitors: Baby or the Bathwater?
- (2012) D. Yee JNCI-Journal of the National Cancer Institute
- IGFBP7 Binds to the IGF-1 Receptor and Blocks Its Activation by Insulin-Like Growth Factors
- (2012) V. Evdokimova et al. Science Signaling
- IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer
- (2012) Rebecca A Mosig et al. Journal of Ovarian Research
- Insulin-Like Growth Factor Binding Proteins: A Structural Perspective
- (2012) Briony E. Forbes et al. Frontiers in Endocrinology
- Receptor Tyrosine Kinases and Targeted Cancer Therapeutics
- (2011) Kenji Takeuchi et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Dual IGF-I/II-Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
- (2011) J. Gao et al. CANCER RESEARCH
- Endoglin Regulates Cancer-Stromal Cell Interactions in Prostate Tumors
- (2011) D. Romero et al. CANCER RESEARCH
- Differential Impacts of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) in Epithelial IGF-Induced Lung Cancer Development
- (2011) Woo-Young Kim et al. ENDOCRINOLOGY
- Targeted therapies for breast cancer
- (2011) Michaela J. Higgins et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product
- (2011) Nighat Sultana JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Targeting IGF-I, IGFBPs and IGF-I Receptor System in Cancer: The Current and Future in Breast Cancer Therapy
- (2011) Lathika Mohanraj et al. Recent Patents on Anti-Cancer Drug Discovery
- Tumor-Associated Retinal Astrocytes Promote Retinoblastoma Cell Proliferation Through Production of IGFBP-5
- (2010) Xiaoliang L. Xu et al. AMERICAN JOURNAL OF PATHOLOGY
- High-yield bacterial expression and structural characterization of recombinant human insulin-like growth factor binding protein-2
- (2010) Monalisa Swain et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Defining the pathway to insulin-like growth factor system targeting in cancer
- (2010) Steven A. Rosenzweig et al. BIOCHEMICAL PHARMACOLOGY
- Treatment of biliary tract cancer with NVP-AEW541: Mechanisms of action and resistance
- (2010) Samuel Wolf WORLD JOURNAL OF GASTROENTEROLOGY
- Perspectives in mammalian IGFBP-3 biology: local vs. systemic action
- (2009) Paulette M. Yamada et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer
- (2009) A J Ryan et al. BRITISH JOURNAL OF CANCER
- Therapeutic antibodies: successes, limitations and hopes for the future
- (2009) Patrick Chames et al. BRITISH JOURNAL OF PHARMACOLOGY
- Spontaneous and reversible self-assembly of a polypeptide fragment of insulin-like growth factor bindingprotein-2 into fluorescent nanotubular structures
- (2009) Monalisa Swain et al. CHEMICAL COMMUNICATIONS
- Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
- (2009) J. Veeken et al. CURRENT CANCER DRUG TARGETS
- Potentiation of Growth Factor Signaling by Insulin-like Growth Factor-binding Protein-3 in Breast Epithelial Cells Requires Sphingosine Kinase Activity
- (2009) Janet L. Martin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Curcumin Synergizes With Resveratrol to Inhibit Colon Cancer
- (2009) Adhip P. N. Majumdar et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- The Role of IGF-1R in Pediatric Malignancies
- (2009) S. Y. Kim et al. ONCOLOGIST
- Insulin-like growth factor binding protein-5 influences pancreatic cancer cell growth
- (2009) Sarah K Johnson et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Insulin, insulin-like growth factors and neoplasia
- (2008) Michael Pollak BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- The Type 1 Insulin-Like Growth Factor Receptor Pathway
- (2008) M. M. Chitnis et al. CLINICAL CANCER RESEARCH
- Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer
- (2008) John SP Yuen et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- IGFBP-2 overexpression reduces the appearance of dysplastic aberrant crypt foci and inhibits growth of adenomas in chemically induced colorectal carcinogenesis
- (2008) Daniela Diehl et al. INTERNATIONAL JOURNAL OF CANCER
- Tea Polyphenols and Their Roles in Cancer Prevention and Chemotherapy
- (2008) Di Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials
- (2008) J. Rodon et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started